by FBorchert | Feb 26, 2024 | News
This year we will start our conference activities in Santiago, Chile for the 7th Theranostics World Congress. From March 22 to 24 you can find us at booth #A06 and talk with Dr. Andreas Kluge and Andreas Fintelmann, our General Managers, about how ABX-CRO can help you...
by FBorchert | Dec 18, 2023 | News
Prostate cancer awareness month may already be over, but men’s health remains an important topic. We are therefore most pleased to announce that ABX-CRO was chosen to collaborate with Curasight in a phase 2 study to improve the diagnosis of prostate cancer. The...
by FBorchert | Oct 5, 2023 | News
We are happy to announce that our last conference this year will be the Targeted Radiopharmaceuticals Summit Europe. Come and find us in Berlin from 5 to 7 December. Join us for our talks: “Using multiple legislations to optimise clinical trial conduct (EU & USA)”...
by FBorchert | Sep 8, 2023 | News
Indian scientists led the way to today´s nuclear medicine: Suresh Srivastava: Fundamental 99mTechnetium generator technology and labelling Nagichettiar Satyamurthy: 18F-labelling methodology & molecular pharmacology Shrikant Deshpande: DOTA as chelator for...
by FBorchert | Aug 11, 2023 | News
On to the next congress – from September 9-13 we will head to Vienna to be part of the 36th Annual Congress of the European Association of Nuclear Medicine – the EANM’23. The EANM industrial exhibition gives an extensive overview of the latest achievements in...
by FBorchert | Jul 14, 2023 | News
After returning from a successful SNMMI in Chicago, we are now excited to participate in the second Targeted Radipharmaceuticals Summit US – the TRP US. Moritz Kallerhoff, ABX-CRO INC.’s Chief Executive Officer, will be on site for us in Boston from July...
